These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32419721)

  • 1. Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19.
    Galimberti F; McBride J; Cronin M; Li Y; Fox J; Abrouk M; Herbst A; Kirsner RS
    Clin Dermatol; 2020; 38(6):775-780. PubMed ID: 32419721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Other novel immunosuppressants.
    Flores F; Kerdel FA
    Dermatol Clin; 2000 Jul; 18(3):475-83, ix. PubMed ID: 10943542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
    Ghazawi FM; Lim M; Dutz JP; Kirchhof MG
    Int J Dermatol; 2020 Sep; 59(9):1043-1056. PubMed ID: 32621284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
    Sadeghinia A; Daneshpazhooh M
    Dermatol Ther; 2021 Jan; 34(1):e14498. PubMed ID: 33141519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
    de Graaf M; Janmohamed SR; Schuttelaar MLA; Agner T; Alfonso JH; De Schepper S; Deleuran M; Despontin K; Elenius V; Ghislain PD; Huilaja L; Johansson EK; Kvenshagen BK; Mandelin JM; Olset H; Svensson A; van Tuyll van Serooskerken AM; Thyssen JP; Vestergaard C
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2153-2165. PubMed ID: 35793471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.
    Paolino G; Mercuri SR; Bearzi P; Mattozzi C
    Dermatol Ther; 2020 Sep; 33(5):e13537. PubMed ID: 32385891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days.
    Karadag AS; Aslan Kayıran M; Lotti T; Wollina U
    Dermatol Ther; 2020 Sep; 33(5):e13686. PubMed ID: 32458530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations.
    Waldman RA; Grant-Kels JM
    J Am Acad Dermatol; 2021 Nov; 85(5):1113-1116. PubMed ID: 34437985
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic.
    Reynolds SD; Mathur AN; Chiu YE; Brandling-Bennett HA; Pope E; Siegel MP; Holland KE; Paller AS; Siegfried EC; Tom WL; Lara-Corrales I; Tollefson MM; Maguiness S; Eichenfield LF; Sugarman J; Frieden IJ; Oza VS; Cipriano SD; Huang JT; Shah SD; Lauren CT; Castelo-Soccio L; McMahon P; Cordoro KM
    Pediatr Dermatol; 2020 May; 37(3):424-434. PubMed ID: 32320494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive agents in Dermatology].
    Bressan AL; Silva RS; Fontenelle E; Gripp AC
    An Bras Dermatol; 2010; 85(1):9-22. PubMed ID: 20464082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].
    Gaudy-Marqueste C
    Ann Dermatol Venereol; 2007 Dec; 134(12):949-56. PubMed ID: 18166916
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
    Callen JP
    Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
    Speeckaert R; Lambert J; Puig L; Speeckaert M; Lapeere H; De Schepper S; van Geel N
    Drugs R D; 2021 Sep; 21(3):341-350. PubMed ID: 34106430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
    Zen M; Saccon F; Gatto M; Montesso G; Larosa M; Benvenuti F; Iaccarino L; Doria A
    Rheumatology (Oxford); 2020 Jul; 59(7):1591-1598. PubMed ID: 31642908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding light on therapeutics in alopecia and their relevance to COVID-19.
    Fagan N; Meah N; York K; Bokhari L; Fletcher G; Chen G; Tobin DJ; Messenger A; Irvine AD; Sinclair R; Wall D
    Clin Dermatol; 2021; 39(1):76-83. PubMed ID: 33972056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E; Tansley SL; McHugh NJ
    Clin Rheumatol; 2015 Dec; 34(12):2089-95. PubMed ID: 26299472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on systemic therapies for atopic dermatitis.
    Denby KS; Beck LA
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation and Discontinuation Rates of Biologics in Dermatology Patients During COVID-19 Pandemic.
    Cohen SR; Kahn JS; Gao DX; Fiumara K; Lam A; Dumont N; Rosmarin D
    J Cutan Med Surg; 2021; 25(6):646-647. PubMed ID: 34107794
    [No Abstract]   [Full Text] [Related]  

  • 19. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Wong SC; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
    Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.